Table of Contents Prev article Next article
October , 2018 Vol 10 issues 5
Mini Review
Quality by Design in Pharmaceutical Formulation: A risk minimization and multidisciplinary approach to manufacturing of medicines

The concept of Quality by Design (QbD) was incorporated into pharmaceutical manufacturing protocol in 2004 after the pharmaceutical cGMP for the 21st century initiative. This concept in pharmaceutical production provides opportunities for enhancing efficiencies, encouraging safety and reducing cost. Quality by Design was implemented by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) and United States Food and Drugs Administration.

The concept of Quality by Design (QbD) was incorporated into pharmaceutical manufacturing protocol in 2004 after the pharmaceutical cGMP for the 21st century initiative. This concept in pharmaceutical production provides opportunities for enhancing efficiencies, encouraging safety and reducing cost. Quality by Design was implemented by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) and United States Food and Drugs Administration.

Categories

  • Original Reseach Articles ( 1 )
  • Reviews ( 0 )
  • Mini Reviews ( 4 )

Special features of jpdip.com

  • Accepting papers in areas of Pharmaceutical and Life Sciences related to Pharmaceutical Development and Manufacturing
  • Provides an online platform for sharing research information among our authors. Digital Pharm Research Network
  • Information on Conferences, Fellowships, Scholarships, Travel Grants